Stay updated on Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The record presents details of a completed Phase I study of pembrolizumab and ibrutinib for unresectable or metastatic melanoma. It includes the study design, eligibility criteria, treatment schedule, outcome measures, and investigator and publication information.
    Difference
    54%
    Check dated 2026-11-09T13:57:00.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The page remains a 403 Forbidden error page, while the displayed site revision changes from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-02T15:54:07.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition and says that some content may use “Super Intelligence” instead of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-26T15:12:52.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.1 to v3.7.2; the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-19T14:51:10.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-12T15:20:09.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    A 403 Forbidden page is displayed, replacing the study content with a minimal header and a Home link, indicating access to the record is blocked.
    Difference
    20%
    Check dated 2026-09-21T22:24:32.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial page.